Back to MW Marshall Wace, LLP

TNGX

13 quarters

Position history for MWMarshall Wace, LLP's holdings in Tango Therapeutics, Inc.

Yes. Marshall Wace holds 174,909 shares of TNGX (Tango Therapeutics), worth $5.5M, as of its Q2 2026 13F filing. It opened the position in Q2 2026.

Current Value

$5.5M

Current Shares

174,909

Total Value Change

+$5.4M

Total Shares Change

+168,640

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
New
174,909
-
$5.5M0.0%$31.26
37
2026-Q1
Exited
0
-100.0%
$00.0%$20.92
0
2025-Q4
Decreased
329,231
-77.9%
$2.9M0.0%$8.86
0
2025-Q3
Decreased
1.5M
-14.5%
$12.5M0.0%$8.40
0
2025-Q2
Decreased
1.7M
-5.4%
$8.9M0.0%$5.12
0
2025-Q1
New
1.8M
-
$2.5M0.0%$1.37
36
2024-Q4
Exited
0
-100.0%
$00.0%$3.09
0
2024-Q3
New
73,122
-
$563,0400.0%$7.47
34
2024-Q2
Exited
0
-100.0%
$00.0%$8.58
0
2024-Q1
New
109,269
-
$867,5960.0%$7.94
34
2022-Q2
Exited
0
-100.0%
$00.0%$4.32
0
2022-Q1
Increased
28,915
+361.2%
$220,0000.0%$7.75
37
2021-Q4
New
6,269
-
$68,0000.0%$10.86
29

Other major holders of TNGX: RTW Investments, LP, BlackRock, Inc., FMR LLC, Farallon Capital Management, L.L.C., Goldman Sachs Group Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used